CTL
|
2
|
3
|
0.80
|
0.365
|
Disruption of hemostasis [27]
|
CREGF
|
1
|
1
|
0.01
|
0.007
|
Substrate recognition and specificity [28]
|
HYAL
|
1
|
1
|
0.20
|
0.089
|
Degradation of extracellular matrix and
|
| | | | |
connective tissue; spreading factor [29]
|
LAAO
|
1
|
3
|
0.88
|
0.403
|
Edema, platelet aggregation, and apoptosis
|
| | | | |
due to the liberation of peroxides [30]
|
NP
|
1
|
1
|
0.70
|
0.321
|
Hypotension [3]
|
NGF
|
1
|
2
|
0.58
|
0.264
|
Induction of apoptosis in neuronal cells [31]
|
NUC
|
1
|
1
|
0.23
|
0.103
|
Liberation of toxic nucleosides [32]
|
PDE
|
1
|
1
|
0.11
|
0.052
|
Hydrolysis of phosphodiester bonds; hypotension [32]
|
PLB
|
1
|
1
|
0.34
|
0.154
|
Unknown; potentially hemolytic and/or cytotoxic [2, 33]
|
VEGF
|
3
|
3
|
1.05
|
0.479
|
Hypotension and augmentation of vascular permeability [34]
|